Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis


Por: Thaçi, D, Puig, L, Papp, K, Gold, LS, Fernández-Peñas, P, Huang, YH, Dossenbach, M, Falques, M, Agell, H, Schönherr, F, Vestergaard, C

Publicada: 1 abr 2025
Resumen:


Filiaciones:
Thaçi, D:
 Univ Lubeck, Inst & Comprehens Ctr Inflammatory Med, Lubeck, Germany

 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

Puig, L:
 Univ Autonoma Barcelona, Hosp Santa Creu i St Pau, Barcelona, Spain

 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

Papp, K:
 Univ Toronto, Alliance Clin Res & Prob Med Res, Waterloo, ON, Canada

 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

Gold, LS:
 Henry Ford Hlth Syst, Detroit, MI USA

 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

Fernández-Peñas, P:
 Univ Sydney, Westmead Hosp, Sydney Med Sch, Sydney, NSW, Australia

 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

Huang, YH:
 Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Taoyuan 333, Taiwan

 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

Dossenbach, M:
 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

 Eli Lilly & Co, Indianapolis, IN USA

Falques, M:
 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

 Almirall SA, Barcelona, Spain

Agell, H:
 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

 Almirall SA, Barcelona, Spain

Schönherr, F:
 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

 Almirall Hermal GmbH, Reinbek, Germany

Vestergaard, C:
 Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan

 Aarhus Univ Hosp, Aarhus, Denmark
ISSN: 16100379





JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Alemania
Tipo de documento: Meeting Abstract
Volumen: 23 Número:
Páginas: 87-88
WOS Id: 001525952600163

MÉTRICAS